ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "heart block and pregnancy"

  • Abstract Number: 1300 • 2017 ACR/ARHP Annual Meeting

    The Italian Registry of Autoimmune Congenital Heart Block (Lu.Ne Registry): Report of the First Year of Activity

    Micaela Fredi1, Laura Andreoli2, Tiziana Bertero3, Alesandra Bortoluzzi4, Silvia Breda5, Veronica Cappa6, Fulvia Ceccarelli7, Rolando Cimaz8, Salvatore De Vita9, Emma Di Poi10, Franco Franceschini11, Maria Gerosa12, Marcello Govoni4, Ariela Hoxha13, Andrea Lojacono14, Luca Marozio15, Alessandro Mathieu16, Antonina Minniti17, Marina Muscarà18, Melissa Padovan4, Matteo Piga16, Roberta Priori7, Véronique Ramoni19, Amelia Ruffatti13, Marta Tonello13, Sonia Zatti20, Stefano Calza6, Antonio Brucato5 and Angela Tincani2, 1Department of Rheumatology and Clinical Immunology, Rheumatology and Clinical Immunology, Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, 2Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, 3Ospedale Mauriziano, Torino, Italy, 4UOC of Rheumatology, University Hospital S. Anna, Cona Ferrara, Italy, 5Struttura Complessa Medicina Interna, ASST Papa Giovanni XXIII, Bergamo, Italy, 6Unit of Biostatistics and Biomathematics & Unit of Bioinformatics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy, 7UO Complessa Reumatologia, Policlinico Umberto I Università Sapienza di Roma, Rome, Italy, 8Pediatric Rheumatology, Anna Meyer Children's Hospital-University of Firenze, Florence, Italy, 9Rheumatology Clinic, Academic Hospital S. M. della Misericordia, Medical Area Department, University of Udine, Italy, Udine, Italy, 10Clinica di Reumatologia, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy, 11Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, 12Istituto Ortopedico Gaetano Pini, University of Milan, Milano, Italy, 13Unità di Reumatologia, Dipartimento di Medicina-DIMED, Università di Padova., Padova, Italy, 14Obstetrics and Gynecology, Spedali Civili and University of Brescia, Brescia, Italy, 15Ginecologia e Ostetricia 1, Dipartimento di Scienze Chirurgiche, Università di Torino, Torino, Italy, 16Unit and Chair of Rheumatology, University Hospital of Cagliari, Cagliari, Italy, 17UO Complessa Reumatologia, Policlinico Umberto I Università Sapienza di Roma, Roma, Italy, 18Reumatologia ASST Ospedale Niguarda, Milano, Italy, 19Rheumatology, Rheumatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy, 20U.O. Ginecologia e Ostetricia ASST Spedali Civili, Brescia, Italy

    Background/Purpose: Neonatal Lupus (NL) is a rare syndrome caused by placental transfer of maternal anti-Ro/SSA and anti-La/SSB autoantibodies to the fetus. Cardiac manifestations may comprise…
  • Abstract Number: 3239 • 2016 ACR/ARHP Annual Meeting

    Expression of IFN-Regulated Genes in Autoantibody Exposed Babies in Utero

    Malin Hedlund1, Gudny-Ella Thorlacius1, Margarita Ivanchenko1, Vijole Ottosson1, Amina Ossoinak1, Linda Lagnefeldt1, Joanna Tingstrom1, Alexander Espinosa1, Lars Rönnblom2, Maija-Leena Eloranta2, Sven-Erik Sonesson1 and Marie Wahren-Herlenius3, 1Department of Medicine, Solna, Unit of Experimental Rheumatology, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Stockholm, Sweden, 2Uppsala University, Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala, Sweden, 3Department of Medicine, Solna, Unit of Experimental Rheumatology, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden

    Background/Purpose: Ro/SSA autoantibodies and an IFN signature are commonly present in women with Sjögren’s syndrome and SLE. During pregnancy, the autoantibodies are transported across the…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology